Cargando…
Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model
BACKGROUND: Donepezil, galantamine, rivastigmine and memantine are potentially effective interventions for cognitive impairment in dementia, but the use of these drugs has not been personalised to individual patients yet. We examined whether artificial intelligence-based recommendations can identify...
Autores principales: | Liu, Qiang, Vaci, Nemanja, Koychev, Ivan, Kormilitzin, Andrey, Li, Zhenpeng, Cipriani, Andrea, Nevado-Holgado, Alejo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805393/ https://www.ncbi.nlm.nih.gov/pubmed/35101059 http://dx.doi.org/10.1186/s12916-022-02250-2 |
Ejemplares similares
-
Validation of UK Biobank data for mental health outcomes: A pilot study using secondary care electronic health records
por: Li, Zhenpeng, et al.
Publicado: (2022) -
Identifying Predictors of Suicide in Severe Mental Illness: A Feasibility Study of a Clinical Prediction Rule (Oxford Mental Illness and Suicide Tool or OxMIS)
por: Senior, Morwenna, et al.
Publicado: (2020) -
Explainable artificial intelligence for mental health through transparency and interpretability for understandability
por: Joyce, Dan W., et al.
Publicado: (2023) -
Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank
por: Newby, Danielle, et al.
Publicado: (2021) -
Harnessing the potential of machine learning and artificial intelligence for dementia research
por: Ranson, Janice M., et al.
Publicado: (2023)